HAVCR2 plays almost the same immunosuppressive functions as PD-1 in glioma (58), and we also found that CD44 shows a consistent correlation with HAVCR2 and PD-1 in glioma (Supplementary Figure 10). This evidence concerns the gene CD44 and central nervous system cancer.